Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
Hoosier Cancer Research Network

Protocol Number
Hoosier GU16-287

To Learn More Call
(201)-510-0950